{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:57:40Z","timestamp":1792112260773,"version":"4.4.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Academy of Child & Adolescent Psychiatry"],"published-print":{"date-parts":[[2004,7]]},"DOI":"10.1097\/01.chi.0000128790.87945.2f","type":"journal-article","created":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T21:36:47Z","timestamp":1094074607000},"page":"859-867","source":"Crossref","is-referenced-by-count":54,"title":["A Pharmacotherapy Algorithm for Stabilization and Maintenance of Pediatric Bipolar Disorder"],"prefix":"10.1016","volume":"43","author":[{"given":"MANI N.","family":"PAVULURI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DAVID B.","family":"HENRY","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BHARGAVI","family":"DEVINENI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JULIE A.","family":"CARBRAY","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MICHAEL W.","family":"NAYLOR","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PHILIP G.","family":"JANICAK","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1097\/01.chi.0000128790.87945.2f_bib1","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1001\/archpsyc.1996.01830050073012","article-title":"A prospective 4-year follow-up study of attention-deficit hyperactivity and related disorders","volume":"53","author":"Biederman","year":"1996","journal-title":"Arch Gen Psychiatry"},{"issue":"suppl 1","key":"10.1097\/01.chi.0000128790.87945.2f_bib2","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1016\/S0165-0327(00)00179-8","article-title":"Maintenance therapies for classic and other forms of bipolar disorder","volume":"59","author":"Bowden","year":"2000","journal-title":"J Affect Disord"},{"key":"10.1097\/01.chi.0000128790.87945.2f_bib3","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0165-0327(98)00211-0","article-title":"Manic symptoms in psychiatrically hospitalized children","volume":"51","author":"Carlson","year":"1998","journal-title":"J Affect Disord"},{"key":"10.1097\/01.chi.0000128790.87945.2f_bib4","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1089\/10445460050167287","article-title":"Stimulant treatment in young boys with symptoms suggesting childhood mania: a report from a longitudinal study","volume":"10","author":"Carlson","year":"2000","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1097\/01.chi.0000128790.87945.2f_bib5","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1097\/00004583-200210000-00011","article-title":"A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania","volume":"41","author":"Delbello","year":"2002","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/01.chi.0000128790.87945.2f_bib6","unstructured":"Faraone S, Biederman J, Wozniak J, Mick E (2003), An open trial of risperidone in treating pediatric bipolar disorder. Atypical antipsychotics: a focus on mood disorders. Paper presented at the 2003 CNS Advisory Summit, Scottsdale, AZ, February"},{"key":"10.1097\/01.chi.0000128790.87945.2f_bib7","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1007\/BF00172631","article-title":"Overview of USA controlled trials of trazodone in clinical depression","volume":"95","author":"Feighner","year":"1988","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1097\/01.chi.0000128790.87945.2f_bib8","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1089\/10445460152595568","article-title":"A prospective open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder","volume":"11","author":"Frazier","year":"2001","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1097\/01.chi.0000128790.87945.2f_bib9","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1097\/00004583-199908000-00011","article-title":"Risperidone treatment for juvenile bipolar disorder: a retrospective chart review","volume":"38","author":"Frazier","year":"1999","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/01.chi.0000128790.87945.2f_bib10","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0165-0327(98)00176-1","article-title":"Prepubertal and young adolescent bipolarity versus ADHD: assessment and validity using the WASH-U-KSADS, CBCL, and TRF","volume":"51","author":"Geller","year":"1998","journal-title":"J Affect Disord"},{"key":"10.1097\/01.chi.0000128790.87945.2f_bib11","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/00004714-200108000-00002","article-title":"A double-blind, randomized, prospective evaluation of the efficacy and safety of risperidone versus haloperidol in the treatment of schizoaffective disorder","volume":"21","author":"Janicak","year":"2001","journal-title":"J Clin Psychopharmacol"},{"key":"10.1097\/01.chi.0000128790.87945.2f_bib12","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1097\/00004583-200112000-00016","article-title":"Adjunctive antipsychotic treatment of adolescents with bipolar psychosis","volume":"40","author":"Kafantaris","year":"2001","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/01.chi.0000128790.87945.2f_bib13","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00131746-200007000-00004","article-title":"Medication treatment of bipolar disorder 2000: a summary of expert consensus guidelines","volume":"6","author":"Kahn","year":"2000","journal-title":"J Psychiatr Pract"},{"key":"10.1097\/01.chi.0000128790.87945.2f_bib14","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S0006-3223(03)00067-2","article-title":"Combination pharmacotherapy in children and adolescents with bipolar disorder","volume":"53","author":"Kowatch","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1097\/01.chi.0000128790.87945.2f_bib15","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/00004583-200006000-00009","article-title":"Effect size of lithium, divalproex sodium and carbamazepine in children and adolescent with bipolar disorder","volume":"39","author":"Kowatch","year":"2000","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/01.chi.0000128790.87945.2f_bib16","first-page":"1","article-title":"Recognition and treatment of pediatric bipolar disorder","volume":"1","author":"Pavuluri","year":"2002","journal-title":"Contemp Psychiatry"},{"key":"10.1097\/01.chi.0000128790.87945.2f_bib17","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/00004583-200303000-00007","article-title":"A feasibility study of the children's medication algorithm project (CMAP) algorithm for the treatment of ADHD","volume":"42","author":"Pliszka","year":"2003","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/01.chi.0000128790.87945.2f_bib18","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1176\/appi.ajp.159.7.1146","article-title":"Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety","volume":"159","author":"Sachs","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1097\/01.chi.0000128790.87945.2f_bib19","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1089\/cap.1998.8.49","article-title":"Risperidone for young children with mood disorders and aggressive behavior","volume":"8","author":"Schreier","year":"1998","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1097\/01.chi.0000128790.87945.2f_bib20","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0165-1781(97)00123-6","article-title":"Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP","volume":"73","author":"Spearing","year":"1997","journal-title":"Psychiatry Res"},{"key":"10.1097\/01.chi.0000128790.87945.2f_bib21","first-page":"430","article-title":"Psychotropic medication and priapism: a comprehensive review","volume":"51","author":"Thompson","year":"1990","journal-title":"J Clin Psychiatry"},{"key":"10.1097\/01.chi.0000128790.87945.2f_bib22","series-title":"Guide to Clinical Preventive Services","author":"U.S. Preventive Services Task Force","year":"1996"},{"key":"10.1097\/01.chi.0000128790.87945.2f_bib23","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1017\/S1092852900018459","article-title":"The psychopharmacologic armamentarium in the pediatric population","volume":"8","author":"Wagner","year":"2003","journal-title":"CNS Spectr"},{"key":"10.1097\/01.chi.0000128790.87945.2f_bib24","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1097\/00004583-200210000-00012","article-title":"An open-label trial of divalproex sodium in children and adolescents with bipolar disorder","volume":"41","author":"Wagner","year":"2002","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/01.chi.0000128790.87945.2f_bib25","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1001\/archpsyc.57.7.675","article-title":"Brief screening for the family history: the Family History Screen","volume":"57","author":"Weissman","year":"2000","journal-title":"Arch Gen Psychiatry"},{"key":"10.1097\/01.chi.0000128790.87945.2f_bib26","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1089\/104454603322163862","article-title":"A systematic chart review of the nature of psychiatric adverse events in children and adolescents treated with selective serotonin reuptake inhibitors","volume":"13","author":"Wilens","year":"2003","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1097\/01.chi.0000128790.87945.2f_bib27","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"Br J Psychiatry"}],"container-title":["Journal of the American Academy of Child & Adolescent Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856709614040?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856709614040?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T06:43:42Z","timestamp":1568184222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890856709614040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["S0890856709614040"],"URL":"https:\/\/doi.org\/10.1097\/01.chi.0000128790.87945.2f","relation":{},"ISSN":["0890-8567"],"issn-type":[{"value":"0890-8567","type":"print"}],"subject":[],"published":{"date-parts":[[2004,7]]}}}